Table 5.

Information on patients with confirmed death and overall survival < 8 months. Complete cohort detailed data may be found in the supplementary data

Patient number	First intervention	Second intervention	Age at 1st surgery	Sex	Presenting symptom	Tumor location	Enhancement pattern	Chemotherapy regimen	KPS at location last follow up	Progression-free survival (months)	Overall survival (month)
9	Needle Bx	N/A	69	M	AMS	L parietal	None	TMZ	60	2.43	7.89
13	Needle Bx	N/A	71	M	Seizures + hallucinations	R temporal	Ring Enhancing	Unknown	Unknown	2.86	2.86
19	Needle Bx	N/A	65	F	Seizures	L temporal	Scant Enhancement	Unknown	50	0.36	0.72
21	Resection	N/A	67	M	Seizures	R parieto-occipital	Moderate Enhancement	TMZ	40	0.36	2.99
25	Needle Bx	N/A	54	F	Headache	Bifrontote mporal + thalamic + Basal ganglia	None	Unknown	Unknown	0.065	0.13